Another Justice Department Web site with a cute name is hanging on to misinformation about the American Medical Association’s position on medical marijuana.

From JustThinkTwice.org:

The American Medical Association has rejected pleas to endorse marijuana as medicine, and instead has urged that marijuana remain a prohibited, Schedule I drug, at least until more research is done.

It’s false, and it needs to change. Please join me in sending an e-mail to AskDOJ@usdoj.gov and asking them to update this language.

Also of note is the relative silence from the drug czar’s office. You would think the Office of National Drug Control Policy would have something to say about a new marijuana position from the nation’s largest medical association, right? Wouldn’t that warrant a press release or blog post? It certainly has whenever the AMA said something negative about marijuana.

I guess they’re showing their true colors. The drug czar’s office isn’t about bringing you up-to-date, factual information on drugs and drug policy. Their job is to make sure you don’t question the laws we have in place — even when it puts them at odds with reality. So when the nation’s largest group of doctors breaks from the government talking points, all we hear is silence.

We’ve been updating readers this week about the American Medical Association’s new position on marijuana and the DEA’s response. Last night, the DEA removed a number of AMA-related talking points from its Web site. This may seem like a very small, almost meaningless step, but it’s important to remember how influential the AMA really is.

Striking this language from the DEA’s Web site is a manifestation of something larger and more abstract: the gutting of our opponents’ most effective talking point.

I know everyone reading this blog has sent a letter to their member of Congress and asked for medical marijuana reforms (If you haven’t, you can here), and I’m willing to bet a lot of you have received negative responses. Think back to that response … did it mention the AMA’s opposition? Chances are it did.

When marijuana prohibition was first debated in 1937, one of the first questions was “What is the AMA’s position?” This line of thinking has been pervasive ever since. In every state where MPP has fought for patients, in every congressional office in Washington, and in countless media debates, prohibitionists have used the AMA’s opposition as their flagship talking point. That they can no longer do so is a major development.

Tonight, after a week of calls by activists, the Drug Enforcement Administration updated its Web site to reflect the American Medical Association’s recent call for a review of marijuana’s Schedule I status.

The update removed several references to the AMA, including: “the American Medical Association recommends that marijuana remain a Schedule I controlled substance,” and “the American Medical Association has rejected pleas to endorse marijuana as medicine.” These changes came just over a week after the AMA released its new position on marijuana.

When it comes to marijuana’s status as a Schedule I drug, there is now a battle between cops and doctors. The cops say it has no medical value, but the doctors — who one might think are in a position to know — either say it does or, at a minimum, want the government to review its stance. And again, medical marijuana advocates are left wondering why the cops have a say in this debate at all. It will be interesting to see how the DEA does characterize the AMA’s new position. MPP will let you know when they do.

Last week’s announcement from the American Medical Association — calling for a federal review of marijuana’s legal status — has been well received in the media, reaching the pages of The Washington Post, LA Times, and other publications. One group that hasn’t got the message is the Drug Enforcement Administration. This is no surprise, as the DEA has been ignoring recommendations to research marijuana’s medical benefits for decades.

But this example is particularly egregious. On the DEA Web page “Exposing the Myth of Smoked Medical Marijuana,” the agency writes, “the American Medical Association recommends that marijuana remain a Schedule I controlled substance.” That statement directly contradicts the new policy that the AMA issued last week.

The DEA also has a contact page where you can call them out on this (likely) willful ignorance of recent news: http://www.justice.gov/dea/contactinfo.htm

Big news: The American Medical Association adopted a new policy position today calling for the review of marijuana’s status as a Schedule I drug.

The revised policy “urges that marijuana’s status as a federal Schedule I controlled substance be reviewed with the goal of facilitating the conduct of clinical research and development of cannabinoid-based medicines, and alternate delivery methods.” While it goes on to explain that the AMA is not stating support for state medical marijuana laws, the new policy does fall in line with what is quickly becoming a universal understanding in American medicine: Marijuana has undeniable medical uses and federal law should reflect that reality.

The new policy marks a historic shift from the AMA’s previous position, which recommended that “marijuana be retained in Schedule I,” grouping marijuana with drugs such as heroin, LSD, and PCP that are deemed to have no accepted medical uses.

The AMA’s previous position was often cited by medical marijuana opponents as evidence that the drug’s medical efficacy was in question. This new policy will go a long way to convincing politicians and policy makers that the compassionate use of medical marijuana should not be blocked by outdated marijuana laws.

Congressman Sam Farr (D-Calif.) introduced the Truth In Trials Act of 2009 today (H.R. 3939), a bill that would give medical marijuana patients and providers the ability to argue in federal court that their actions were legal under state law.

Currently, a federal judge cannot consider state-level legality during a medical marijuana case. For example, Charles Lynch, a California resident who was on trial for operating a medical marijuana clinic that by all accounts operated in compliance with state law, was unable to defend himself by citing California’s medical marijuana law. And consequently, Lynch received a year-long jail sentence. He’s just one of more than 100 people who were prosecuted under federal law during the Bush administration while being denied the right to defend themselves adequately in court.

The Truth In Trials Act would provide an affirmative defense for medical marijuana patients operating within the bounds of state law. If passed, it will protect patients and providers from disgraceful prosecutions in federal court.

While the Truth In Trials Act represents only a small step in the fight for substantive, national medical marijuana reforms, it will bring a fundamental fairness to federal medical marijuana trials. Please write your member of Congress and ask him or her to co-sponsor this bill. At MPP’s online action center, writing Congress is quick and easy.

Congressman Barney Frank, author of two important marijuana policy reform bills (H.R. 2835 and H.R. 2943), responded to a question about the direction of marijuana policy reform today on the Web site reddit.com. See the video below for his take on where the movement is headed.

A new Gallup poll released today shows 44% support for making marijuana legal in the U.S., a record high for this particular poll. The poll also shows 53% support in the west.

While we’ve seen higher numbers in the past, and the level of support varies from poll to poll, this recent number shows a trend that’s undeniable: Americans are quickly realizing that taxing and regulating marijuana is preferable to prohibition.

The chart below shows the change in attitudes among various groups. Notice that all of them have increased since 2005.